Literature DB >> 1736613

Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways.

M Haissaguerre1, B Fischer, T Labbé, P Lemétayer, P Montserrat, C d'Ivernois, J F Dartigues, J F Warin.   

Abstract

The effect of successful catheter ablation of overt accessory pathways on the incidence of atrial fibrillation (AF) was studied in 129 symptomatic patients with (n = 75) or without (n = 54) previous documented AF. Fourteen had had ventricular fibrillation. Factors predictive of recurrence were examined, including electrophysiologic parameters. Atrial vulnerability was defined as induction of sustained AF (greater than 1 minute) using single, then double, atrial extrastimuli at 2 basic pacing cycle lengths. When compared to patients with only reciprocating tachycardia, patients with clinical AF included more men (77 vs 54%, p = 0.008) and were older (35 +/- 12 vs 29 +/- 12 years, p = 0.01). They had a significantly shorter cycle length leading to anterograde accessory pathway block (252 +/- 42 vs 298 +/- 83 ms, p less than 0.001), greater incidences of atrial vulnerability (89 vs 24%, p less than 0.001) and subsequent need for cardioversion (51 vs 15%, p less than 0.001). After discharge, the follow-up period was 35 +/- 12 months (range 18 to 76); 7 patients with previous spontaneous AF (9%) had recurrence at a mean of 10 months after ablation. Age, presence of structural heart disease accessory pathway location, atrial refractory periods and accessory pathway anterograde conduction parameters were not predictive of AF recurrence. Persistence of atrial vulnerability after ablation was the only factor associated with further recurrence of AF. Atrial vulnerability was observed after ablation in only 56% of patients with previous AF versus 89% before ablation. It is concluded that successful catheter ablation of accessory pathways prevents further recurrence of AF in 91% of patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1736613     DOI: 10.1016/0002-9149(92)90992-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Latent atrial fibrillation triggers originating in accessory pathways.

Authors:  Rafael J Ramirez; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2008-06-27       Impact factor: 6.343

Review 2.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 3.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

4.  Perception and documentation of arrhythmias after successful radiofrequency catheter ablation of accessory pathways.

Authors:  H Oddsson; H Walfridsson; N Edvardsson
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-07       Impact factor: 1.468

Review 5.  Atrial Fibrillation in the Wolff-Parkinson-White Syndrome.

Authors:  Osmar Antonio Centurion
Journal:  J Atr Fibrillation       Date:  2011-05-04

6.  Maximum P-wave duration and P-wave dispersion predict recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.

Authors:  Kudret Aytemir; Basri Amasyali; Sedat Kose; Ayhan Kilic; Gulcan Abali; Ali Oto; Ersoy Isik
Journal:  J Interv Card Electrophysiol       Date:  2004-08       Impact factor: 1.900

7.  Evaluation of atrial vulnerability immediately after radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome.

Authors:  Kumral Ergun Cagli; Serkan Topaloglu; Dursun Aras; Nihat Sen; Ibrahim Akpinar; Akif Durak; Halil Lutfi Kisacik
Journal:  J Interv Card Electrophysiol       Date:  2009-10-21       Impact factor: 1.900

Review 8.  [Radiofrequency catheter ablation of atrial flutter and atrial fibrillation].

Authors:  C Reithmann; E Hoffmann; G Steinbeck
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

9.  Relationship between accessory pathway location and occurrence of atrial fibrillation in patients with atrioventricular re-entrant tachycardia.

Authors:  Longle Ma; Yibo Li; Yingli Wang; Xiaohua Wang; Jingbo Kong; Lexin Wang
Journal:  Exp Clin Cardiol       Date:  2004

Review 10.  Radiofrequency Ablation to Prevent Sudden Cardiac Death.

Authors:  Moustapha Atoui; Sampath Gunda; Dhanunjaya Lakkireddy; Srijoy Mahapatra
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.